The global prevalence and ethnic heterogeneity of iron-refractory iron deficiency anaemia - Fan, Shanghua; Zhao, Ting; Sun, Liu (medRxiv, 2023)
Background Iron-refractory iron deficiency anaemia (IRIDA) is an autosomal recessive iron deficiency anaemia caused by mutations in the TMPRSS6 gene. Iron deficiency anaemia is common, whereas IRIDA is rare. The prevalence of IRIDA is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of IRIDA using Genome Aggregation Database (gnomAD) data.Methods The pathogenicity of TMPRSS6 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) standards and guidelines. The minor allele frequency (MAF) of TMPRSS6 gene disease-causing variants in 141456 unique individuals was examined to estimate the global prevalence of IRIDA in seven ethnicities: African/African American (afr), American Admixed/Latino (amr), Ashkenazi Jewish (asj), East Asian (eas), Finnish (fin), Non-Finnish European (nfe) and South Asian (sas). The global and population-specific carrier frequencies and genetic prevalence of IRIDA were calculated using the Hardy-Weinberg equation.Results In total, 86 pathogenic/likely pathogenic variants (PV/LPV) were identified according to ACMG/AMP guideline. The global carrier frequency and genetic prevalence of IRIDA were 2.02 per thousand and 1.02 per million, respectively.Conclusions The prevalence of IRIDA is greater than previous estimates.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Yunnan Fundamental Research Projects (grant No. 202101AU070007).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets are available online in the Science Data Bank (ScienceDB) repository. https://doi.org/10.11922/sciencedb.01515 TMPRSS6transmembrane serine protease 6IRIDAiron refractory iron deficiency anaemiaMAFminor allele frequencyClinGenClinical GenomeNCBINational Center for Biotechnology InformationACMGAmerican College of Medical Genetics and GenomicsAMPAssociation for Molecular PathologyVCEPVariant Curation Expert PanelCIconfidence intervalgnomADGenome Aggregation DatabaseIDiron deficiencyIDAiron deficiency anaemiaPTVsprotein-truncating variantsACallele countAFallele frequencyANallele number